ATM safeguards liver homeostasis by mitigating mitochondrial hypermetabolism and bioenergetic crisis in MASLD
Year: 2026
Type: article
Abstract: The rising incidence of Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive stage, Metabolic dysfunction-associated steatohepatitis (MASH), represents the most prevalent chronic liver condition and a major health problem. Key molecular mechanisms driving this progression remain unclear. We demonstrate that Replication stress (RS) is a dominant hallmark across all stages of human MASLD, while an ATM-mediated DNA Damage Response (DDR) signature is specifically associated with advanced, fibrosing MASH. Using a preclinical MASLD model, we show that ATM (Ataxia-Telangiectasia Mutated) serves as a critical metabolic safeguard. Hepatocyte-specific deletion of ATM significantly worsens liver damage and fibrosis. Mechanistically, ATM-deficient MASLD hepatocytes exhibit increased oxygen consumption and accelerated TCA cycle flux, driving a metabolic surge accompanied by proton leak, ROS production and mitophagy. This mitochondrial dysfunction results in severe hepatic nucleotide pool imbalance, energy deficit and toxic lipid accumulation. Together, these findings reveal that, beyond its canonical role in DNA repair, ATM safeguards liver homeostasis by restraining mitochondrial hypermetabolism and preventing bioenergetic crisis during MASLD progression.
Source: EMBO Molecular Medicine
Authors: Pierre Cordier, Maëlle Cadiou, Christelle Kabore, Solenne Marmier, Alice Verdier, Irene Portolés, Maëva Saroul-Aïnama, Jing Fang, Joana Gonçalves Araujo, Qiyuan He, Isabelle Galy-Fauroux, Romain Donne, Ivan Nemazanyy, Marie Lhomme, Hanna Kulyk, Floriant Bellvert, Sandra Lacas-Gervais, Enora Le Questel, Joel T Haas, Delphine Eberlé, Bart Staels, Jody Valk, Sven M Francque, Marie Lagouge, Jean-Pierre Couty, Philippe Gual, Fatima Mechta-Grigoriou, Géraldine Gentric, Séverine Celton-Morizur, Chantal Desdouets
Institutions: Inserm, Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, La Ligue Contre le Cancer, Centre National de la Recherche Scientifique, Structure fédérative de recherche Necker, Fondation pour l’innovation en Cadiométabolisme et Nutrition, Institut National des Sciences Appliquées de Toulouse, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Toulouse Biotechnology Institute, Bio & Chemical Engineering, Université de Toulouse, Université Côte d'Azur, Université de Lille, Institut Pasteur de Lille, Centre Hospitalier Universitaire de Lille, Antwerp University Hospital, University of Antwerp, Unité de recherche sur les maladies cardiovasculaires et métaboliques, Centre Méditerranéen de Médecine Moléculaire, Université Paris Sciences et Lettres, Institut Curie, Institut Gustave Roussy
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $7,990
Funders: Institut des maladies génétiques Imagine, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Ligue Contre le Cancer, Centre National de la Recherche Scientifique, Institut National Du Cancer, Association Française pour l'Etude du Foie, Universitair Ziekenhuis Antwerpen, HORIZON EUROPE Framework Programme, European Research Council, Labex Immuno-Oncology
OpenAlex ID: W7225872887
